1. Home
  2. BRIA vs PMVP Comparison

BRIA vs PMVP Comparison

Compare BRIA & PMVP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BRIA
  • PMVP
  • Stock Information
  • Founded
  • BRIA 2011
  • PMVP 2013
  • Country
  • BRIA Singapore
  • PMVP United States
  • Employees
  • BRIA N/A
  • PMVP N/A
  • Industry
  • BRIA
  • PMVP Medicinal Chemicals and Botanical Products
  • Sector
  • BRIA
  • PMVP Health Care
  • Exchange
  • BRIA NYSE
  • PMVP Nasdaq
  • Market Cap
  • BRIA 86.3M
  • PMVP 85.5M
  • IPO Year
  • BRIA 2024
  • PMVP 2020
  • Fundamental
  • Price
  • BRIA $3.16
  • PMVP $1.37
  • Analyst Decision
  • BRIA
  • PMVP Strong Buy
  • Analyst Count
  • BRIA 0
  • PMVP 3
  • Target Price
  • BRIA N/A
  • PMVP $5.33
  • AVG Volume (30 Days)
  • BRIA 18.6K
  • PMVP 142.5K
  • Earning Date
  • BRIA 02-19-2025
  • PMVP 02-27-2025
  • Dividend Yield
  • BRIA N/A
  • PMVP N/A
  • EPS Growth
  • BRIA N/A
  • PMVP N/A
  • EPS
  • BRIA 92.24
  • PMVP N/A
  • Revenue
  • BRIA $55,755,669.00
  • PMVP N/A
  • Revenue This Year
  • BRIA N/A
  • PMVP N/A
  • Revenue Next Year
  • BRIA N/A
  • PMVP N/A
  • P/E Ratio
  • BRIA $0.03
  • PMVP N/A
  • Revenue Growth
  • BRIA 8.03
  • PMVP N/A
  • 52 Week Low
  • BRIA $2.90
  • PMVP $1.32
  • 52 Week High
  • BRIA $4.38
  • PMVP $2.26
  • Technical
  • Relative Strength Index (RSI)
  • BRIA N/A
  • PMVP 41.50
  • Support Level
  • BRIA N/A
  • PMVP $1.37
  • Resistance Level
  • BRIA N/A
  • PMVP $1.46
  • Average True Range (ATR)
  • BRIA 0.00
  • PMVP 0.04
  • MACD
  • BRIA 0.00
  • PMVP 0.00
  • Stochastic Oscillator
  • BRIA 0.00
  • PMVP 33.33

About BRIA BRILLIA INC

BrilliA Inc is engaged in business of sales and marketing of lingerie's products including bra, panty and body suit, mainly serving the American, European and other markets.

About PMVP PMV Pharmaceuticals Inc.

PMV Pharmaceuticals Inc is a precision oncology company. The company is engaged in the research and development of small molecule, tumor-agnostic therapies targeting p53 mutations, which has the ability to eliminate cancer cells.

Share on Social Networks: